Revive Closes Over 1.4 Million in Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

TORONTO, Feb. 11, 2019 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company“) (TSX VENTURE: RVV) (OTCQB: RVVTF) is pleased to announce that it has completed the second tranche of the previously announced in the December 7, 2018, January 23, 2019 and February 4, 2019 news releases non-brokered private placement of units of the Company (“Units”), at a price of $0.10 per Unit (the “Offering”). The second tranche of the Offering consisted of the sale of 3,050,000 Units, for the aggregate gross proceeds of both tranches of the Offering of $1,401,000.

Each Unit consists of one common share of Revive (a “Common Share”) and one whole Common Share purchase warrant (each warrant, a “Warrant”).  Each Warrant entitles the holder

... read more at: https://globenewswire.com/news-release/2019/02/11/1716477/0/en/Revive-Closes-Over-1-4-Million-in-Non-Brokered-Private-Placement.html

by

Leave a Reply